SCHEMBL23950347

SCHEMBL23950347

CC(C)c1n[nH]c(=O)c2cc(C3CC3(F)F)nn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23950336 0.82 NLRP3 (0.39)
SCHEMBL23950159 0.74 PARP1 (0.37)
SCHEMBL23950197 0.73 NLRP3 (0.46)
SCHEMBL23950157 0.73 GAA (0.30)
SCHEMBL23950339 0.70 AURKA (0.31)
SCHEMBL23950371 0.70 PDE4B (0.37)
SCHEMBL23950345 0.69 PARP1 (0.36)
SCHEMBL23950368 0.69 GAA (0.30)
SCHEMBL23950525 0.66 PDE4B (0.39)
SCHEMBL30149245 0.64 PDE4B (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203044-A1 PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 US disclosed
US-20230203044-A1 PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 US disclosed
WO-2021209552-A1 PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY JANSSEN PHARMACEUTICA NV (BE) 2021-10-21 WO disclosed